Literature DB >> 3103729

Effect of chloroquine on insulin and glucose homoeostasis in normal subjects and patients with non-insulin-dependent diabetes mellitus.

G D Smith, T A Amos, R Mahler, T J Peters.   

Abstract

Plasma glucose, insulin, and C peptide concentrations were determined after an oral glucose load in normal subjects and in a group of patients with non-insulin-dependent diabetes mellitus before and during a short course of treatment with chloroquine. In the control group there was a small but significant reduction in fasting blood glucose concentration but overall glucose tolerance and hormone concentrations were unaffected. In contrast, the patients with non-insulin-dependent diabetes mellitus showed a significant improvement in their glucose tolerance, which paralleled the severity of their diabetes. This response seems to reflect decreased degradation of insulin rather than increased pancreatic output. These observations suggest that treatment with chloroquine or suitable analogues may be a new approach to the management of diabetes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3103729      PMCID: PMC1245517          DOI: 10.1136/bmj.294.6570.465

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  9 in total

1.  Hypoglycaemia and antimalarial drugs: quinidine and release of insulin.

Authors:  R E Phillips; S Looareesuwan; N J White; P Chanthavanich; J Karbwang; W Supanaranond; R C Turner; D A Warrell
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-17

2.  Insulin resistance: a common feature of diabetes mellitus.

Authors:  C R Kahn
Journal:  N Engl J Med       Date:  1986-07-24       Impact factor: 91.245

Review 3.  Extraction of insulin by liver.

Authors:  J B Field
Journal:  Annu Rev Med       Date:  1973       Impact factor: 13.739

4.  The localization in rat liver of alkaline phosphodiesterase to a discrete organelle implicated in ligand internalization.

Authors:  G D Smith; T J Peters
Journal:  Biochim Biophys Acta       Date:  1982-05-05

5.  In vivo chloroquine-induced inhibition of insulin degradation in a diabetic patient with severe insulin resistance.

Authors:  B R Blazar; C B Whitley; A E Kitabchi; M Y Tsai; J Santiago; N White; F B Stentz; D M Brown
Journal:  Diabetes       Date:  1984-12       Impact factor: 9.461

6.  Insulin processing by the liver.

Authors:  J F Caro; G Muller; J A Glennon
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

7.  The effects of low temperature and chloroquine on 125I-insulin degradation by the perfused rat liver.

Authors:  P A Dennis; N N Aronson
Journal:  Arch Biochem Biophys       Date:  1981-11       Impact factor: 4.013

8.  Degradation of endocytosed insulin in rat liver is mediated by low-density vesicles.

Authors:  R J Pease; G D Smith; T J Peters
Journal:  Biochem J       Date:  1985-05-15       Impact factor: 3.857

9.  Mode of uptake and degradation of 125I-labelled insulin by isolated hepatocytes and H4 hepatoma cells.

Authors:  S Terris; C Hofmann; D F Steiner
Journal:  Can J Biochem       Date:  1979-06
  9 in total
  17 in total

Review 1.  Effects of drugs on glucose tolerance in non-insulin-dependent diabetics (Part II).

Authors:  S O'Byrne; J Feely
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

Review 2.  A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role.

Authors:  Mirella P Hage; Marwa R Al-Badri; Sami T Azar
Journal:  Ther Adv Endocrinol Metab       Date:  2014-08       Impact factor: 3.565

3.  Hydroxychloroquine: a diabetic drug in disguise?

Authors:  Lydia Kang; Ted R Mikuls; James R O'Dell
Journal:  BMJ Case Rep       Date:  2009-03-02

Review 4.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

5.  High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors.

Authors:  Cecilia P Chung; Ingrid Avalos; Annette Oeser; Tebeb Gebretsadik; Ayumi Shintani; Paolo Raggi; C Michael Stein
Journal:  Ann Rheum Dis       Date:  2006-08-10       Impact factor: 19.103

6.  Antidiabetogenic effects of hydroxychloroquine on insulin sensitivity and beta cell function: a randomised trial.

Authors:  Mary Chester M Wasko; Candace K McClure; Sheryl F Kelsey; Kimberly Huber; Trevor Orchard; Frederico G S Toledo
Journal:  Diabetologia       Date:  2015-07-22       Impact factor: 10.122

Review 7.  Management of non-insulin-dependent diabetes mellitus.

Authors:  P J Lefèbvre; A J Scheen
Journal:  Drugs       Date:  1992       Impact factor: 9.546

8.  Chloroquine modulation of specific metabolizing enzymes activities: investigation with selective five drug cocktail.

Authors:  A Adedoyin; R F Frye; K Mauro; R A Branch
Journal:  Br J Clin Pharmacol       Date:  1998-09       Impact factor: 4.335

9.  Chloroquine differentially modulates coronary vasodilation in control and diabetic mice.

Authors:  Qian Zhang; Atsumi Tsuji-Hosokawa; Conor Willson; Makiko Watanabe; Rui Si; Ning Lai; Ziyi Wang; Jason X-J Yuan; Jian Wang; Ayako Makino
Journal:  Br J Pharmacol       Date:  2020-01-08       Impact factor: 8.739

Review 10.  Treatment of non-insulin-dependent diabetes mellitus and its complications. A state of the art review.

Authors:  A Ilarde; M Tuck
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.